Cubist Cubicin Ads Draw FDA Warning Letter For Broad Indication Claims
Executive Summary
Cubist Cubicin journal ads and website claims for treatment of all infections caused by Staphylococcus aureus pose a "significant public health risk," an FDA warning letter to the company says